Dominant negative mutations of the tumor suppressor CCAAT/enhancer binding protein α (C/EBP α):: Role in acute myeloid leukemia.

被引：0
|
作者：
Pabst, T
Mueller, BU
Schnittger, S
Behre, G
Hiddemann, W
Tenen, DG
机构：
[1] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Boston, MA USA
[2] Univ Munich, Klinikum Grosshadern, Dept Med 3, D-8000 Munich, Germany
来源：
BLOOD | 1999年 / 94卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2772
引用
收藏
页码：624A / 624A
页数：1
相关论文
共 50 条
  • [1] Dominant-negative mutations of CEBPA, encoding CCAAT/enhancer binding protein-α (C/EBPα), in acute myeloid leukemia
    Pabst, T
    Mueller, BU
    Zhang, P
    Radomska, HS
    Narravula, S
    Schnittger, S
    Behre, G
    Hiddemann, W
    Tenen, DG
    NATURE GENETICS, 2001, 27 (03) : 263 - 270
  • [2] Dominant-negative mutations of CEBPA, encoding CCAAT/enhancer binding protein-α (C/EBPα), in acute myeloid leukemia
    Thomas Pabst
    Beatrice U. Mueller
    Pu Zhang
    Hanna S. Radomska
    Sailaja Narravula
    Susanne Schnittger
    Gerhard Behre
    Wolfgang Hiddemann
    Daniel G. Tenen
    Nature Genetics, 2001, 27 : 263 - 270
  • [3] Dual epigenetic control of CCAAT/enhancer binding protein α (C/EBPα) expression in acute myeloid leukemia
    Hackanson, Bjoern
    Bennett, Kristi L.
    Brena, Rommlo M.
    Jiang, Jinmai
    Maharry, Katie
    Whitman, Susan P.
    Schmittgen, Thomas D.
    Luebbert, Michael
    Marcucci, Guido
    Bloomfield, Clara D.
    Plass, Christoph
    BLOOD, 2007, 110 (11) : 630A - 630A
  • [4] Tumor suppressor activity of CCAAT/enhancer binding protein alpha is epigenetically down-regulated in acute myeloid leukemia
    Lin, Tsung-Chin
    Lee, Cheng-Yeh
    Tien, Hwei-Fang
    Hu, Chung-Yi
    Tang, Jih-Luh
    Lin, Liang-In
    BLOOD, 2007, 110 (11) : 629A - 630A
  • [5] CCAAT/enhancer binding proteins can supress myeloid leukemia.
    Truong, BTH
    Park, DJ
    Lodie, TA
    Koeffler, HP
    Tenen, DG
    Kogan, SC
    BLOOD, 2000, 96 (11) : 573A - 573A
  • [6] Epigenetic modification of CCAAT/enhancer binding protein α expression in acute myeloid leukemia
    Hackanson, Bjoern
    Bennett, Kristi L.
    Brena, Romulo M.
    Jiang, Jinmai
    Claus, Rainer
    Chen, Shih-Shih
    Blagitko-Dorfs, Nadya
    Maharry, Katie
    Whitman, Susan P.
    Schmiittgen, Thomas D.
    Luebbert, Michael
    Marcucci, Guido
    Bloomfield, Clara D.
    Plass, Christoph
    CANCER RESEARCH, 2008, 68 (09) : 3142 - 3151
  • [7] The C/EBPδ tumor suppressor is silenced by hypermethylation in acute myeloid leukemia
    Agrawal, Shuchi
    Hofmann, Wolf-Karsten
    Tidow, Nicola
    Ehrich, Mathias
    van den Boom, Dirk
    Koschmieder, Steffen
    Berdel, Wolfgang E.
    Serve, Hubert
    Mueller-Tidow, Carsten
    BLOOD, 2007, 109 (09) : 3895 - 3905
  • [8] Evidence for allelic evoluion of C/EBP alpha mutations in acute myeloid leukemia.
    Tiesmeier, J
    Czwalinna, A
    Muller-Tidow, C
    Serve, H
    Krauter, J
    Heil, G
    Ganser, A
    Verbeek, W
    BLOOD, 2003, 102 (11) : 867A - 867A
  • [9] Decreased expression of CCAAT/enhancer binding protein ζ (C/EBPζ) in patients with different myeloid diseases
    Qian, J
    Chen, ZX
    Lin, J
    Wang, W
    Cen, JN
    LEUKEMIA RESEARCH, 2005, 29 (12) : 1435 - 1441
  • [10] Aberrant methylation of CCAAT/enhancer binding protein zeta promoter in acute myeloid leukemia
    Yao, Dong-Ming
    Qian, Jun
    Lin, Jiang
    Wang, Ya-Li
    Chen, Qin
    Qian, Zhen
    Li, Yun
    Wang, Cui-Zhu
    Yang, Jing
    LEUKEMIA RESEARCH, 2011, 35 (07) : 957 - 960
12345